Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Cispharma Inc.
WARNING LETTER
•Cispharma Inc.•April 23, 2012

Cispharma Inc. – FDA Warning Letter, Apr 23, 2012

Record Details

The FDA issued a Warning Letter to Cispharma, Inc. following a March-April 2012 inspection, identifying significant and repeat violations of current Good Manufacturing Practice (CGMP) regulations (21 CFR Parts 210 and 211). These violations render their drug products adulterated under 21 U.S.C. 351(a)(2)(B). The FDA noted a lack of a robust quality system, with several deficiencies recurring from a January 2011 inspection.

Key violations include: 1. **Inadequate Investigations (21 CFR 211.192):** Failure to thoroughly investigate unexplained discrepancies, such as commingled tablets and an employee accident, with insufficient corrective actions proposed. 2. **Inadequate Production and Process Controls (21 CFR 211.100(a)):** Lack of adequate validation for coating processes for Salsalate, Acetaminophen, and Aspirin tablets, leading to quality issues like surface erosion, chipping, and specks, and reliance on end-product sorting instead of process control. 3. **Unsound Specifications and Test Procedures (21 CFR 211.160(b)):** Failure to validate test procedures and establish proper integration parameters for chromatographic methods. 4. **Inadequate Identity Testing of Components (21 CFR 211.84(d)(2

Company
Cispharma Inc.
Inspection date
April 23, 2012
Product type
Drugs
Office
New Jersey District Office
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · 938fdf7e-37ac-43f0-a3a5-a464245de5a2

Violation Codes9
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.19221 CFR 211.100(a)21 CFR 211.160(b)21 CFR 211.84(d)(2)21 U.S.C. 356C(a)(1)FD&C Act 501(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Other documents for Cispharma Inc.
  • EIR - 2010-11-12November 12, 2010

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cispharma Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.